Table 6 Analysis between clinical stage and HPV 16 variants
From: Role of HPV 16 variants among cervical carcinoma samples from Northeastern Brazil
Characteristics | HPV 16 variants | |||
|---|---|---|---|---|
A (n = 23) | B (n = 2) | C (n = 2) | D (n = 20) | |
Clinical stage (FIGO) | ||||
I | 4 | 0 | 0 | 3 |
II | 8 | 0 | 1 | 4 |
III | 9 | 2 | 1 | 10 |
IV | 0 | 0 | 0 | 3 |
NI | 2 | 0 | 0 | 0 |